Metastasis in neuroblastoma:
the MYCN question

dc.contributor.author	Bhavsar, Swapnil
dc.date.accessioned	2023-08-18T08:38:42Z
dc.date.available	2023-08-18T08:38:42Z
dc.date.issued	2023-05-18
dc.description.abstract	Oncogenic drivers like MYCN in neuroblastoma subsets continues to present a significant challenge owing to its strong correlation with high-risk metastatic disease and poor prognosis. However, only a limited number of MYCN-regulatory proteins associated with tumor initiation and progression have been elucidated. In this minireview, I summarize the recent progress in understanding the functional role of MYCN and its regulatory partners in neuroblastoma metastasis.	en_US
dc.identifier.citation	Bhavsar SP. Metastasis in neuroblastoma: the MYCN question. Frontiers in Oncology. 2023	en_US
dc.identifier.cristinID	FRIDAID 2151779
dc.identifier.doi	https://doi.org/10.3389/fonc.2023.1196861
dc.identifier.issn	2234-943X
dc.identifier.uri	https://hdl.handle.net/10037/30062
dc.language.iso	eng	en_US
dc.publisher	Frontiers Media	en_US
dc.relation.journal	Frontiers in Oncology
dc.rights.accessRights	openAccess	en_US
dc.rights.holder	Copyright 2023 The Author(s)	en_US
dc.rights.uri	https://creativecommons.org/licenses/by/4.0	en_US
dc.rights	Attribution 4.0 International (CC BY 4.0)	en_US
dc.title	Metastasis in neuroblastoma: the MYCN question	en_US
dc.type.version	publishedVersion	en_US
dc.type	Journal article	en_US
dc.type	Tidsskriftartikkel	en_US
dc.type	Peer reviewed	en_US

Except where otherwise noted, this item's license is described as Attribution 4.0 International (CC BY 4.0)